USANA Health Sciences, Inc. (USNA) Financial Statements
USANA Health Sciences, Inc. (USNA) reported trailing twelve-month revenue of $913.4M (up 1.6% year on year) and net income of -$22.2M as of 2026-07-04, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $15.9M.
Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason
USNAUSANA Health Sciences, Inc.Follow USNA — free
—
Price chart with a free account
- Market cap
- 257.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 9 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Jan 21 | FY2021 Jan 22 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19 | 1.06 | 1.13 | 1.19 | 1.00 | 0.92 | 0.85 | 0.93 | 0.91 | |
| Gross profit | 0.99 | 0.87 | 0.93 | 0.97 | 0.80 | 0.74 | 0.69 | 0.72 | 0.71 | |
| Research & development | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — | |
| Operating income | 0.19 | 0.15 | 0.18 | 0.17 | 0.11 | 0.09 | 0.07 | 0.04 | -0.00 | |
| Pre-tax income | 0.19 | 0.15 | 0.18 | 0.17 | 0.11 | 0.10 | 0.08 | 0.04 | 0.00 | |
| Income tax | 0.07 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | |
| Net income | 0.13 | 0.10 | 0.12 | 0.12 | 0.07 | 0.06 | 0.04 | 0.01 | -0.02 | |
| Diluted EPS ($) | 5.12 | 4.41 | 5.86 | 5.73 | 3.59 | 3.30 | 2.19 | 0.58 | -1.20 | |
| Diluted shares (bn) | 0.025 | 0.023 | 0.021 | 0.020 | 0.019 | 0.019 | 0.019 | 0.019 | — |
USD billions · SEC XBRL
USANA Health Sciences, Inc. — questions
- What is USANA Health Sciences, Inc.'s revenue?
- $913.4M over the twelve months to 2026-07-04, up 1.6% year on year, from its 10-Q and 10-K filings.
- What is USANA Health Sciences, Inc.'s net income?
- -$22.2M over the twelve months to 2026-07-04.
- What is USANA Health Sciences, Inc.'s free cash flow?
- $15.9M over the twelve months to 2026-07-04.
- What are USANA Health Sciences, Inc.'s diluted earnings per share?
- $-1.20 over the twelve months to 2026-07-04.
Every figure on this page comes from USANA Health Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.